Skip to main content
Medical information Clinical review pending

Infection Testing

Torch Panel Avidity IgG Test

The Torch Panel Avidity IgG Test helps detect recent or past infections (Toxoplasma, Rubella, Cytomegalovirus) that can affect pregnancy. It measures antibody avidity to determine infection timing.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (1.5 mL minimum) serum collected in an SST tube.
Results
Results typically available the same day if the sample is received by 9 am on Monday, Wednesday, or Friday. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 3,205

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Torch Panel Avidity IgG Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Pregnant women.
  • ✓Women planning pregnancy.
  • ✓Individuals with symptoms suggestive of TORCH infections (e.g., fever, rash, fatigue, swollen lymph nodes).
  • ✓Individuals with known exposure to TORCH infections.
  • ✓Monitoring for congenital infection risk.
02

In plain language

What this test helps you understand

This test helps determine if an infection occurred recently or in the past, which is important for managing risks during pregnancy. Low avidity IgG antibodies suggest a recent infection, potentially posing a risk to the fetus, while high avidity suggests a past infection.
The Torch Panel Avidity IgG Test is a diagnostic tool used to identify infections that can potentially affect pregnant women and their unborn children. The TORCH acronym stands for Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, and Herpes Simplex Virus. This specific test focuses on measuring the avidity (binding strength) of IgG antibodies to Toxoplasma, Rubella, and Cytomegalovirus. Understanding the avidity of these antibodies provides important information about when the infection occurred, which is crucial for assessing the risk to a developing fetus. High avidity generally suggests a past infection, while low avidity may indicate a more recent infection. This test is particularly relevant for pregnant women or those planning pregnancy to understand potential risks and guide prenatal care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample3 mL (1.5 mL minimum) serum collected in an SST tube.
MethodologyEnzyme Immunoassay (EIA).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects IgG antibodies and their avidity for Toxoplasma, Rubella, and Cytomegalovirus. It does not test for all TORCH infections (e.g., Herpes Simplex Virus, Syphilis). Results must be interpreted in the context of clinical presentation and other relevant tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Avidity refers to the binding strength of antibodies. Low avidity suggests a recent infection, while high avidity suggests a past infection.
Certain infections can pose risks to the developing fetus. This test helps determine if a recent infection occurred, allowing for appropriate management and monitoring during pregnancy.
This panel tests for Toxoplasma, Rubella, and Cytomegalovirus (CMV).
No special preparation, such as fasting, is required for this test.
Results will indicate the level of IgG antibodies and their avidity. Your doctor will interpret these results based on your individual circumstances.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp